General MedicationsNASALGeneric

MIACALCIN

CALCITONIN SALMON

Standard Dose

200 IU/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview MIACALCIN is listed in Drugs@FDA under application 020313 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CALCITONIN SALMON Form and strength SPRAY, METERED;NASAL - 200 IU/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2017-09-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview MIACALCIN is listed in Drugs@FDA under application 020313 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CALCITONIN SALMON Form and strength SPRAY, METERED;NASAL - 200 IU/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2017-09-12 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.